European Journal of Pharmaceutics and Biopharmaceutics

Article	Citations
Microneedle array systems for long-acting drug delivery	132
Dissolving microneedle-mediated dermal delivery of itraconazole nanocrystals for improved treatment of cutaneous candidiasis	103
Exosomes as drug delivery systems: A brief overview and progress update	94
Versatility of hydrogel-forming microneedles in in vitro transdermal delivery of tuberculosis drugs	70
Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases	68
Freeze-drying of nanoparticles: How to overcome colloidal instability by formulation and process optimization	66
Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer’s disease	63
Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo	58
3D-Printing with precise layer-wise dose adjustments for paediatric use via pressure-assisted microsyringe printing	57
Oral inhalation for delivery of proteins and peptides to the lungs	54
Etravirine-loaded dissolving microneedle arrays for long-acting delivery	53
Recent developments in stimuli-responsive polymer nanogels for drug delivery and diagnostics: A review	52
Nose-to-brain drug delivery system with ligand/cell-penetrating peptide-modified polymeric nano-micelles for intracerebral gliomas	51
Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems	49
Combinatorial lipid-nanosystem for dermal delivery of 5-fluorouracil and resveratrol against skin cancer: Delineation of improved dermatokinetics and epidermal drug deposition enhancement analysis	49
Biomimetic platelet membrane-coated nanoparticles for targeted therapy	47
Treatment of acute lung inflammation by pulmonary delivery of anti-TNF-α siRNA with PAMAM dendrimers in a murine model	47
Stent coating by electrospinning with chitosan/poly-cyclodextrin based nanofibers loaded with simvastatin for restenosis prevention	45
Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies	45
Exosome-loaded hydrogels: A new cell-free therapeutic approach for skin regeneration	44
Evolution of drug-eluting biomedical implants for sustained drug delivery	43
Recent update of toxicity aspects of nanoparticulate systems for drug delivery	43
Recent advances in prodrug-based nanoparticle therapeutics	40
Enhanced efficacy and drug delivery with lipid coated mesoporous silica nanoparticles in cancer therapy	39
Applications of nanotechnology in 3D printed tissue engineering scaffolds	39

Etoposide and olaparib polymer-coated nanoparticles within a bioadhesive sprayable hydrogel for post-surgical localised delivery to brain tumours	38
Quicker, deeper and stronger imaging: A review of tumor-targeted, near-infrared fluorescent dyes for fluorescence guided surgery in the preclinical and clinical stages	38
Current status and future opportunities for incorporation of dissolution data in PBPK modeling for pharmaceutical development and regulatory applications: OrBiTo consortium commentary	37
A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C10)	37
Lipid-polymer hybrid nanoparticles carrying linezolid improve treatment of methicillin-resistant Staphylococcus aureus (MRSA) harbored inside bone cells and biofilms	37
Long-acting nanoparticle-loaded bilayer microneedles for protein delivery to the posterior segment of the eye	37
An integrated computational methodology with data-driven machine learning, molecular modeling and PBPK modeling to accelerate solid dispersion formulation design	37
Trends in drug- and vaccine-based dissolvable microneedle materials and methods of fabrication	36
N-acetyl-d-glucosamine-conjugated PAMAM dendrimers as dual receptor-targeting nanocarriers for anticancer drug delivery	36
Next-generation contact lenses: Towards bioresponsive drug delivery and smart technologies in ocular therapeutics	36
Pharmacokinetic investigation of synthetic cannabidiol oral formulations in healthy volunteers	36
Design, development and in-vitro/in-vivo evaluation of intranasally delivered Rivastigmine and N-Acetyl Cysteine loaded bifunctional niosomes for applications in combinative treatment of Alzheimer’s d	35
Pharmaceutical salts/cocrystals of enoxacin with dicarboxylic acids: Enhancing in vitro antibacterial activity of enoxacin by improving the solubility and permeability	35
Therapy for the individual: Towards patient integration into the manufacturing and provision of pharmaceuticals	35
Artificial neural networks applied to quality-by-design: From formulation development to clinical outcome	35
Synergistic activity of phage PEV20-ciprofloxacin combination powder formulation—A proof-of-principle study in a P. aeruginosa lung infection model	34
Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability	33
Co-encapsulation of docetaxel and thymoquinone in mPEG-DSPE-vitamin E TPGS-lipid nanocapsules for breast cancer therapy: Formulation optimization and implications on cellular and in vivo toxicity	33
GMP-compliant sponge-like dressing containing MSC lyo-secretome: Proteomic network of healing in a murine wound model	33
Physical formulation approaches for improving aqueous solubility and bioavailability of ellagic acid: A review	33
Acceptability of an orodispersible film compared to syrup in neonates and infants: A randomized controlled trial	33
Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions	32
Binder jetting 3D printing of challenging medicines: From low dose tablets to hydrophobic molecules	32
Sustained release of growth factors from photoactivated platelet rich plasma (PRP)	32
Berberine encapsulated PEG-coated liposomes attenuate Wnt1/β-catenin signaling in rheumatoid arthritis via miR-23a activation	31
Charge reversible hyaluronic acid-modified dendrimer-based nanoparticles for siMDR-1 and doxorubicin co-delivery	31
Validation of hyaluronic acid-agar-based hydrogels as vitreous humor mimetics for in vitro drug and particle migration evaluations	30
Customized fast-separable microneedles prepared with the aid of 3D printing for nanoparticle delivery	30
Design, fabrication, and characterisation of a silicon microneedle array for transdermal therapeutic delivery using a single step wet etch process	30
Chick embryo chorioallantoic membrane as a suitable in vivo model to evaluate drug delivery systems for cancer treatment: A review	29
Influence of short term storage conditions, concentration methods and excipients on extracellular vesicle recovery and function	29
Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery	29
Improved multidetector asymmetrical-flow field-flow fractionation method for particle sizing and concentration measurements of lipid-based nanocarriers for RNA delivery	29
Impact of formulation on the quality and stability of freeze-dried nanoparticles	29
Kidney-targeted astaxanthin natural antioxidant nanosystem for diabetic nephropathy therapy	29
Thermosensitive hydrogels for local delivery of 5-fluorouracil as neoadjuvant or adjuvant therapy in colorectal cancer	28
An overview of gastrointestinal mucus rheology under different pH conditions and introduction to pH-dependent rheological interactions with PLGA and chitosan nanoparticles	28
Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery	28
Converting nanosuspension into inhalable and redispersible nanoparticles by combined in-situ thermal gelation and spray drying	28
Understanding the role of colon-specific microparticles based on retrograded starch/pectin in the delivery of chitosan nanoparticles along the gastrointestinal tract	27
Cholinium-based ionic liquids as bioinspired hydrotropes to tackle solubility challenges in drug formulation	27
QbD-driven development of intranasal lipid nanoparticles for depression treatment	27
Spray-dried multidrug particles for pulmonary co-delivery of antibiotics with N-acetylcysteine and curcumin-loaded PLGA-nanoparticles	27
Antimicrobial and antibiofilm photodynamic therapy against vancomycin resistant Staphylococcus aureus (VRSA) induced infection in vitro and in vivo	27
In situ gelling drug delivery systems for topical drug delivery	27
Deep learning for continuous manufacturing of pharmaceutical solid dosage form	27
Evaluation of bovine milk extracellular vesicles for the delivery of locked nucleic acid antisense oligonucleotides	27
Quantitative estimation of drug permeation through nasal mucosa using in vitro membrane permeability across Calu-3 cell layers for predicting in vivo bioavailability after intranasal administration to	26
Emerging drug delivery strategies for idiopathic pulmonary fibrosis treatment	26
Phenylboronic acid modified nanoparticles simultaneously target pancreatic cancer and its metastasis and alleviate immunosuppression	26

What is the fate of multi-lamellar liposomes of controlled size, charge and elasticity in artificial and animal skin?	26
Study on the fabrication and characterization of tip-loaded dissolving microneedles for transdermal drug delivery	26
Quantitative comparison of three widely-used pulmonary administration methods in vivo with radiolabeled inhalable nanoparticles	26
Supercritical fluid technology for the development of innovative ophthalmic medical devices: Drug loaded intraocular lenses to mitigate posterior capsule opacification	26
Biogenic silver nanoparticles: In vitro and in vivo antitumor activity in bladder cancer	26
Trends-process analytical technology in solid oral dosage manufacturing	25
A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment	25
An ultrasound responsive microbubble-liposome conjugate for targeted irinotecan-oxaliplatin treatment of pancreatic cancer	25
IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies	25
Lyophilization and nebulization of pulmonary surfactant-coated nanogels for siRNA inhalation therapy	25
A primary drying model-based comparison of conventional batch freeze-drying to continuous spin-freeze-drying for unit doses	25
Stomach pH before vs. after different bariatric surgery procedures: Clinical implications for drug delivery	25
Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic	25
Elucidating inhaled liposome surface charge on its interaction with biological barriers in the lung	25
Protein stability during nebulization: Mind the collection step!	25
Lipid-based mucus penetrating nanoparticles and their biophysical interactions with pulmonary mucus layer	25
Model predictive control in pharmaceutical continuous manufacturing: A review from a user’s perspective	24
Size shifting of solid lipid nanoparticle system triggered by alkaline phosphatase for site specific mucosal drug delivery	24
Phosphorylated PEG-emulsifier: Powerful tool for development of zeta potential changing self-emulsifying drug delivery systems (SEDDS)	24
Nanoparticles carrying fingolimod and methotrexate enables targeted induction of apoptosis and immobilization of invasive thyroid cancer	24
Gastro-protective protein-silica nanoparticles formulation for oral drug delivery: In vitro release, cytotoxicity and mitochondrial activity	24
Design of experiments and design space approaches in the pharmaceutical bioprocess optimization	24
Overcoming the diverse mechanisms of multidrug resistance in lung cancer cells by photodynamic therapy using pTHPP-loaded PLGA-lipid hybrid nanoparticles	24
Lipid-encapsulated upconversion nanoparticle for near-infrared light-mediated carbon monoxide release for cancer gas therapy	23
In vivo safety assessment, biodistribution and toxicology of polyvinyl alcohol microneedles with 160-day uninterruptedly applications in mice	23
The influence of drug and polymer particle size on the in situ amorphization using microwave irradiation	23
Cocrystal formulations: A case study of topical formulations consisting of ferulic acid cocrystals	23
Wavelength dependent photo-cytotoxicity to ovarian carcinoma cells using temoporfin loaded tetraether liposomes as efficient drug delivery system	23
Drug-eluting wound dressings having sustained release of antimicrobial compounds	23
A liposome-micelle-hybrid (LMH) oral delivery system for poorly water-soluble drugs: Enhancing solubilisation and intestinal transport	23
Liquid crystalline nanoparticles for drug delivery: The role of gradient and block copolymers on the morphology, internal organisation and release profile	22
Xylan in drug delivery: A review of its engineered structures and biomedical applications	22
Formulating monoclonal antibodies as powders for reconstitution at high concentration using spray-drying: Trehalose/amino acid combinations as reconstitution time reducing and stability improving form	22
Robustness of aerosol delivery of amikacin liposome inhalation suspension using the eFlow® Technology	22
Structure-mechanics and improved tableting performance of the drug-drug cocrystal metformin:salicylic acid	22
Microparticle encapsulation of a tuberculosis subunit vaccine candidate containing a nanoemulsion adjuvant via spray drying	22
Application of solid lipid nanoparticles as a long-term drug delivery platform for intramuscular and subcutaneous administration: In vitro and in vivo evaluation	22
Kaolinite group minerals: Applications in cancer diagnosis and treatment	22
3D characterisation of dry powder inhaler formulations: Developing X-ray micro computed tomography approaches	22
Pre-formulation and delivery strategies for the development of bacteriocins as next generation antibiotics	21
Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers	21
Delivery of ionizable hydrophilic drugs based on pharmaceutical formulation of ion pairs and ionic liquids	21
Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effects in the treatment of pancreatic cancer	21
Hydrophobic ion pairing (HIP) of (poly)peptide drugs: Benefits and drawbacks of different preparation methods	21
Nanomedicine in osteosarcoma therapy: Micelleplexes for delivery of nucleic acids and drugs toward osteosarcoma-targeted therapies	21
Controlled release of tetracycline hydrochloride from poly(ω-pentadecalactone-co-ε-caprolactone)/gelatin nanofibers	21
Preclinical challenges for developing long acting intravitreal medicines	21
Biological studies of an ICG-tagged aptamer as drug delivery system for malignant melanoma	21
ADAM 8 as a novel target for doxorubicin delivery to TNBC cells using magnetic thermosensitive liposomes	21
Establishment of a clinically relevant specification for dissolution testing using physiologically based pharmacokinetic (PBPK) modeling approaches	20
Isolation methods of large and small extracellular vesicles derived from cardiovascular progenitors: A comparative study	20
Combination of magnetic targeting with synergistic inhibition of NF-κB and glutathione via micellar drug nanomedicine enhances its anti-tumor efficacy	20
A new mathematical model for monitoring the temporal evolution of the ice crystal size distribution during freezing in pharmaceutical solutions	20
Biodegradable pH-responsive micelles loaded with 8-hydroxyquinoline glycoconjugates for Warburg effect based tumor targeting	20
“Felodipine-indomethacin” co-amorphous supersaturating drug delivery systems: “Spring-parachute” process, stability, in vivo bioavailability, and underlying molecular mechanisms	20
An overview of the production methods for core–shell microspheres for parenteral controlled drug delivery	20
Bioinspired hyaluronic acid and polyarginine nanoparticles for DACHPt delivery	20
Impact of media material and process parameters on breakage kinetics–energy consumption during wet media milling of drugs	20
An in vitro dissolution–digestion–permeation assay for the study of advanced drug delivery systems	20
Functionalized PLGA nanoparticles prepared by nano-emulsion templating interact selectively with proteins involved in the transport through the blood-brain barrier	20
Pegfilgrastim (PEG-G-CSF) induces anti-PEG IgM in a dose dependent manner and causes the accelerated blood clearance (ABC) phenomenon upon repeated administration in mice	19
Probiotic nasal spray development by spray drying	19
Physiological properties, composition and structural profiling of porcine gastrointestinal mucus	19
Six years of progress in the oral biopharmaceutics area – A summary from the IMI OrBiTo project	19
Small scale design of experiment investigation of equilibrium solubility in simulated fasted and fed intestinal fluid	19
Intratympanic application of poloxamer 407 hydrogels results in sustained N-acetylcysteine delivery to the inner ear	19
Acceptability of small-sized oblong tablets in comparison to syrup and mini-tablets in infants and toddlers: A randomized controlled trial	19
Coupling quaternary ammonium surfactants to the surface of liposomes improves both antibacterial efficacy and host cell biocompatibility	19
Bitter-blockers as a taste masking strategy: A systematic review towards their utility in pharmaceuticals	19
Enhancing ovarian cancer conventional chemotherapy through the combination with cannabidiol loaded microparticles	19
Natural sesame oil is superior to pre-digested lipid formulations and purified triglycerides in promoting the intestinal lymphatic transport and systemic bioavailability of cannabidiol	19
Characterization of attributes and in vitro performance of exenatide-loaded PLGA long-acting release microspheres	19
3D printed systems for colon-specific delivery of camptothecin-loaded chitosan micelles	18
Microemulsion-based gel for the transdermal delivery of rasagiline mesylate: In vitro and in vivo assessment for Parkinson’s therapy	18
In vitro model for predicting the access and distribution of drugs in the brain using hCMEC/D3 cells	18
Preparation of camptothecin micelles self-assembled from disodium glycyrrhizin and tannic acid with enhanced antitumor activity	18
Potential drug delivery nanosystems for improving tumor penetration	18
Collagenase loaded chitosan nanoparticles for digestion of the collagenous scar in liver fibrosis: The effect of chitosan intrinsic collagen binding on the success of targeting	18
Predicting human pharmacokinetics of liposomal temoporfin using a hybrid in silico model	18
Surface-engineered nanoliposomes with lipidated and non-lipidated peptide-dendrimeric scaffold for efficient transdermal delivery of a therapeutic agent: Development, characterization, toxicological a	18

Inhibition of multi-drug resistant Klebsiella pneumoniae: Nanoparticles induced photoinactivation in presence of efflux pump inhibitor	18
High frequency acoustic nebulization for pulmonary delivery of antibiotic alternatives against Staphylococcus aureus	18
Microneedles for Extended Transdermal Therapeutics: A Route to Advanced Healthcare	18
Electrospinning/electrospraying coatings for metal microneedles: A design of experiments (DOE) and quality by design (QbD) approach	18
Sequential administration of PEG-Span 80 niosome enhances anti-tumor effect of doxorubicin-containing PEG liposome	17
Composite nanofibers incorporating alpha lipoic acid and atorvastatin provide neuroprotection after peripheral nerve injury in rats	17
Therapeutic peptides for chemotherapy: Trends and challenges for advanced delivery systems	17
In vitro and in vivo evaluation of organic solvent-free injectable melatonin nanoformulations	17
Improving tumor hypoxia and radiotherapy resistance via in situ nitric oxide release strategy	17
Application of the GastroDuo to study the interplay of drug release and gastric emptying in case of immediate release Aspirin formulations	17
Polyphenols against infectious diseases: Controlled release nano-formulations	17
A physiologically-based nanocarrier biopharmaceutics model to reverse-engineer the in vivo drug release	17
Spray dried powders for nasal delivery: Process and formulation considerations	17
Novel insights on the encapsulation mechanism of PLGA terminal groups on ropivacaine	17
Profiling skin penetration using PEGylated emulsifiers as penetration enhancers via confocal Raman spectroscopy and fluorescence spectroscopy	17
Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound – A promising starting point for future PUMA applications	17
Oral Drug Delivery: Conventional to Long Acting New-Age Designs	17
In vivo biocompatibility and efficacy of dexamethasone-loaded PLGA-PEG-PLGA thermogel in an alkali-burn induced corneal neovascularization disease model	17
Lipid-encapsulated oral therapeutic peptide vaccines reduce tumour growth in an orthotopic mouse model of colorectal cancer	17
An investigation into the effects of geometric scaling and pore structure on drug dose and release of 3D printed solid dosage forms	17
Impact of structural relaxation on mechanical properties of amorphous polymers	16
Combination of mesenchymal stem cells and bioactive molecules in hydrogels for osteoarthritis treatment	16
Engineering large porous microparticles with tailored porosity and sustained drug release behavior for inhalation	16
Cyclodextrin nanosponge as a temoporfin nanocarrier: Balancing between accumulation and penetration in 3D tumor spheroids	16
Age-appropriate solid oral formulations for pediatric applications with a focus on multiparticulates and minitablets: Summary of September 2019 EuPFI workshop	16
Electrospun Nimodipine-loaded fibers for nerve regeneration: Development and in vitro performance	16
Effect of obesity on gastrointestinal transit, pressure and pH using a wireless motility capsule	16
Mucoadhesive brinzolamide-loaded nanofibers for alternative glaucoma treatment	16
A rapid millifluidic synthesis of tunable polymer-protein nanoparticles	16
In silico evaluation of particle transport and deposition in the airways of individual patients with chronic obstructive pulmonary disease	16
Pulmonary drug absorption and systemic exposure in human: Predictions using physiologically based biopharmaceutics modeling	16
Exploring high pressure nebulization of Pluronic F127 hydrogels for intraperitoneal drug delivery	16
The combined disulfide cross-linking and tyrosine-modification of very low molecular weight linear PEI synergistically enhances transfection efficacies and improves biocompatibility	16
Modified cyclodextrin-based nanoparticles mediated delivery of siRNA for huntingtin gene silencing across an in vitro BBB model	16
Improved imiquimod-induced psoriasis like dermatitis using microneedles in mice	16
Mannosylated glycoliposomes for the delivery of a peptide kappa opioid receptor antagonist to the brain	16
Nanocarriers for the topical treatment of psoriasis - pathophysiology, conventional treatments, nanotechnology, regulatory and toxicology	16
Release kinetics of fluorescent dyes from PLGA nanoparticles in retinal blood vessels: In vivo monitoring and ex vivo localization	15
Fabrication of a shell-core fixed-dose combination tablet using fused deposition modeling 3D printing	15
Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease	15
Investigation of transfollicular caffeine penetration using microdialysis on ex vivo porcine ear skin	15
Controlled polysorbate 20 hydrolysis – A new approach to assess the impact of polysorbate 20 degradation on biopharmaceutical product quality in shortened time	15
Dopamine-loaded lipid based nanocarriers for intranasal administration of the neurotransmitter: A comparative study	15
An in vitro model for assessing drug transport in cystic fibrosis treatment: Characterisation of the CuFi-1 cell line	15
Detection of amorphous-amorphous phase separation in small molecular co-amorphous mixtures with SEM-EDS	15
Ocular pharmacokinetics of atenolol, timolol and betaxolol cocktail: Tissue exposures in the rabbit eye	15
From powder to tablets: Investigation of residence time distributions in a continuous manufacturing process train as basis for continuous process verification	15
Current approaches to facilitate improved drug delivery to the central nervous system	15
About the impact of superassociation of hydrophobic ion pairs on membrane permeability	15
Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia	15
Vinpocetine loaded ultradeformable liposomes as fast dissolving microneedle patch: Tackling treatment challenges of dementia	15
Optimization of the quality by design approach for gene therapy products: A case study for adeno-associated viral vectors	15
A concise review of metallic nanoparticles encapsulation methods and their potential use in anticancer therapy and medicine	15
Entrapment of silver nanoparticles in L-α-phosphatidylcholine/cholesterol-based liposomes mitigates the oxidative stress in human keratinocyte (HaCaT) cells	15
Quality by design steered development of Niclosamide loaded liposomal thermogel for Melanoma: In vitro and Ex vivo evaluation	15
Streptomycin sulphate loaded solid lipid nanoparticles show enhanced uptake in macrophage, lower MIC in Mycobacterium and improved oral bioavailability	15
The immunogenicity of an anti-EGFR single domain antibody (VHH) is enhanced by misfolded amorphous aggregation but not by heat-induced aggregation	15
Fatty acid chain length impacts nanonizing capacity of albumin-fatty acid nanomicelles: Enhanced physicochemical property and cellular delivery of poorly water-soluble drug	15
Patchless administration of canine influenza vaccine on dog’s ear using insertion-responsive microneedles (IRMN) without removal of hair and its in vivo efficacy evaluation	15
Lipopolysaccharide Structure and the Phenomenon of Low Endotoxin Recovery	14
Combining enabling formulation strategies to generate supersaturated solutions of delamanid: In situ salt formation during amorphous solid dispersion fabrication for more robust release profiles	14
Intestinal permeation enhancers enable oral delivery of macromolecules up to 70 kDa in size	14
Dissolution enhancement of carbamazepine using twin-screw melt granulation	14
Multidimensional analysis of human intestinal fluid composition	14
Foams as unique drug delivery systems	14
A phospholipid-based formulation for the treatment of airway inflammation in chronic respiratory diseases	14
In vitro prediction of in vivo absorption of ibuprofen from suspensions through rational choice of dissolution conditions	14
Mesalazine and inflammatory bowel disease – From well-established therapies to progress beyond the state of the art	14
Lecithin-based nanoemulsions of traditional herbal wound healing agents and their effect on human skin cells	14
Therapeutic efficacy and gastrointestinal biodistribution of polycationic nanoparticles for oral camptothecin delivery in early and late-stage colorectal tumor-bearing animal model	14
Incorporation of phosphatidylserine improves efficiency of lipid based gene delivery systems	14
Novel approach for overcoming the stability challenges of lipid-based excipients. Part 1: Screening of solid-state and physical properties of polyglycerol esters of fatty acids as advanced pharmaceuti	14
Study of double-targeting nanoparticles loaded with MCL-1 siRNA and dexamethasone for adjuvant-induced arthritis therapy	14
Intact multi-attribute method (iMAM): A flexible tool for the analysis of monoclonal antibodies	14
The effect of buffer species on biorelevant dissolution and precipitation assays – Comparison of phosphate and bicarbonate buffer	14
Air-liquid interface (ALI) impact on different respiratory cell cultures	14
Heat flux sensor to create a design space for freeze-drying development	14
Investigation of silicon nanoparticles produced by centrifuge chemical vapor deposition for applications in therapy and diagnostics	13
Sustained release of PKR inhibitor C16 from mesoporous silica nanoparticles significantly enhances mRNA translation and anti-tumor vaccination	13
Porous particles and novel carrier particles with enhanced penetration for efficient pulmonary delivery of antitubercular drugs	13
Effect of supersaturation on absorption of indomethacin and tadalafil in a single pass intestinal perfusion rat model, in the absence and presence of a precipitation inhibitor	13
Therapeutic deep eutectic solvents: A comprehensive review of their thermodynamics, microstructure and drug delivery applications	13
Mechanistic understanding of salt-induced drug encapsulation in nanosuspension via acid-base neutralization as a nanonization platform technology to enhance dissolution rate of pH-dependent poorly wat	13
Exploiting disease-induced changes for targeted oral delivery of biologics and nanomedicines in inflammatory bowel disease	13
Understanding dexamethasone kinetics in the rabbit tear fluid: Drug release and clearance from solution, suspension and hydrogel formulations	13
Nanoparticle-based immunotherapy of breast cancer using recombinant Helicobacter pylori proteins	13
Design of the ocular coil, a new device for non-invasive drug delivery	13
Binding of excipients is a poor predictor for aggregation kinetics of biopharmaceutical proteins	13
Nanobiosensors for detection of opioids: A review of latest advancements	13
Synergistic application of twin-screw granulation and selective laser sintering 3D printing for the development of pharmaceutical dosage forms with enhanced dissolution rates and physical properties	13
Recent studies on the processes and formulation impacts in the development of solid dispersions by hot-melt extrusion	13
Rational and practical considerations to guide a target product profile for patient-centric drug product development with measurable patient outcomes – A proposed roadmap	13
Optimizing ophthalmic delivery of a poorly water soluble drug from an aqueous in situ gelling system	13
On the usefulness of compendial setups and tiny-TIM system in evaluating the in vivo performance of oral drug products with various release profiles in the fasted state: Case example sodium salt of A6	13
Peptide-lipid nanoconstructs act site-specifically towards glioblastoma growth impairment	13